Camtek Ltd (CAMT)
Official siteTECHNOLOGY • SEMICONDUCTOR EQUIPMENT & MATERIALS • NASDAQ
Market Cap: $4.36B
Last updated: Nov 17, 2026 at 4:34 PM ET
Camtek Ltd (CAMT) Statistics
Camtek (CAMT) has a market cap of $4.36B and an enterprise value of $4.57B. Its share count is up 12.55% from a year earlier. Its trailing P/E of 30.8x is above its 10-year median of 23.2x.
Total Valuation
Enterprise value is 4.79% above the market cap, as debt exceeds cash.
| Market Cap | $4.36B |
|---|---|
| Enterprise Value | $4.57B |
| Latest price (Nov 17, 2026) | $94.96 |
Key Dates
The next earnings report is expected on Feb 16, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Feb 16, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 4, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 9.0x and 6.5x. Its year-end P/E ranged from 11.7x to 35.6x from 2016 to 2025.
| P/E Ratio | 30.8x |
|---|---|
| Forward P/E | 25.8x |
| P/S Ratio | 9.0x |
| Forward P/S | 7.3x |
| P/B Ratio | 6.5x |
| P/TBV Ratio | 7.8x |
| P/FCF Ratio | 212.5x |
| PEG Ratio | 1.8 |
Enterprise Valuation
Counting debt and cash, the company is valued at 38.6x EBITDA and 221.6x free cash flow.
| EV / Earnings | 34.2x |
|---|---|
| EV / Sales | 8.4x |
| EV / EBITDA | 38.6x |
| EV / FCF | 221.6x |
Price Statistics
The stock is down 1.28% over 52 weeks and trades 27.91% below its 50-day average.
| Beta (1Y) | 2.87 |
|---|---|
| 52-Week Change | -1.28% |
| 1-Month Change | -26.35% |
| 3-Month Change | -36.97% |
| 6-Month Change | -37.24% |
| 5-Year Change | +200.18% |
| 10-Year Change | +3923.45% |
| Total Return (1Y) | -1.28% |
| Total Return (3Y CAGR) | +16.19% |
| Total Return (5Y CAGR) | +16.52% |
| Return vs SPY (1Y) | -11.35% |
| Max Drawdown (1Y) | -55.69% |
| Max Drawdown (3Y) | -63.16% |
| Sharpe Ratio (1Y) | 0.00 |
| Correlation with SPY (1Y) | 0.54 |
| 50-Day Average | $131.72 |
| 200-Day Average | $154.86 |
| 52-Week Range | $89.13 to $215.99 |
| RSI (14 Days) | 34.5 |
| Average Volume (20 Days) | 559.09K |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 5.85x current liabilities, and total debt is 0.65x shareholder equity.
| Current Ratio | 5.85x |
|---|---|
| Quick Ratio | 5.18x |
| Debt / Equity | 0.65x |
| Debt / EBITDA | 3.70x |
Returns and Efficiency
Return on invested capital is 3.56% over the last 12 months, against a 5-year average of 11.41%.
| Return on Equity (ROE) | 17.72% |
|---|---|
| Return on Assets (ROA) | 9.45% |
| Return on Invested Capital (ROIC) | 3.56% |
| ROIC (5Y Average) | 11.41% |
| Asset Turnover | 0.41x |
| Inventory Turnover | 2.65x |
| Receivables Turnover | 3.40x |
| Cash Conversion Cycle | 172 days |
Taxes
Income tax took 14.52% of pretax income over the last 12 months.
| Income Tax (TTM) | $22.71M |
|---|---|
| Effective Tax Rate | 14.52% |
Scores
CAMT has an Altman Z-Score of 6.07, in the safe zone above 2.99, and a Piotroski F-Score of 5 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 6.07 |
|---|---|
| Altman Z Zone | Safe |
| Piotroski F-Score | 5 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue of $544.32M over the last 12 months is up 12.18% from the 12 months before.
| Revenue | $544.32M |
|---|---|
| Revenue Growth (YoY) | +12.18% |
| Gross Profit | $272.33M |
| Operating Income | $126.01M |
| Pretax Income | $156.39M |
| Net Income | $133.68M |
| Reported EPS (TTM) | $3.08 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 53.13% of the $1.42B in total assets.
| Cash and Equivalents | $280.65M |
|---|---|
| Total Debt | $489.18M |
| Net Debt | $208.54M |
| Net Debt Per Share | $4.05 |
| Working Capital | $755.97M |
| Shareholder Equity | $754.48M |
| Book Value Per Share | $14.65 |
| Tangible Book Value | $625.71M |
| Tangible Book Per Share | $12.15 |
| Total Assets | $1.42B |
| Total Liabilities | $660.73M |
Balance sheet as of Sep 30, 2026.
Cash Flow
| Capital Expenditures | $0 |
|---|---|
| FCF Per Share | $0.49 |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is 23.15%.
| Gross Margin | 50.03% |
|---|---|
| Operating Margin | 23.15% |
| Pretax Margin | 28.73% |
| Net Margin | 24.56% |
Growth
| EPS Growth (3Y CAGR) | +18.39% |
|---|---|
| EPS Growth (5Y CAGR) | +37.28% |
| Book Value Per Share Growth (2Y CAGR) | +12.90% |
| Tangible Book Per Share Growth (2Y CAGR) | +16.67% |
Dividends and Yields
CAMT does not pay a dividend. Its free cash flow yield is 0.47%.
| Earnings Yield | 3.25% |
|---|---|
| FCF Yield | 0.47% |
| Shareholder Yield | 0.00% |
Peer Position
Against 10 similar companies, CAMT has the 5th highest P/E and the 7th highest ROIC.
P/E RatioPeer median 29.4x
P/S RatioPeer median 4.6x
ROICPeer median 4.26%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +28.56%
| P/E Ratio | 30.8x vs 29.4x median |
|---|---|
| P/S Ratio | 9.0x vs 4.6x median |
| ROIC | 3.56% vs 4.26% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +12.18% vs +28.56% median |
Analyst Forecast
Consensus estimates put EPS growth at 28.29% a year over the next 2 fiscal years.
| EPS Growth Forecast (2Y CAGR) | +28.29% |
|---|
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About CAMT
What is CAMT's market cap?
Camtek has a market cap of $4.36B. Its enterprise value, which adds debt and subtracts cash, is $4.57B.
What is CAMT's P/E ratio?
Camtek has a trailing P/E ratio of 30.8x and a forward P/E of 25.8x.
How many shares of CAMT are outstanding?
Camtek has 51.50M shares outstanding. The count is up 12.55% from a year earlier.
Does CAMT pay a dividend?
No. Camtek does not pay a dividend.
How much debt does CAMT have?
Camtek has $489.18M of total debt and $280.65M of cash and equivalents, a net debt position of $208.54M.
CAMT pages: Overview, Charting, Earnings, Forecast, Statistics, Valuation, Competitors